Despite these spatial differences in progression patterns, the proton group exhibited a longer median progression-free survival (PFS) compared to the photon group (9.56 months vs 6.77 months, respectively), although the difference did not reach statistical significance ( P = . 116).
← all excerpts
Imaging patterns of glioblastoma progression: Comparative analysis of sequential proton boost versus conventional photon therapy.
1
0.1160
0.1160